NATIONAL JEWISH HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
Active, not recruiting
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 80
- Registration Number
- NCT04353752
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
Recruiting
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2020-04-10
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT04341532
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
Recruiting
- Conditions
- Cancer
- Interventions
- Drug: systemic corticosteroid or biologic
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 238
- Registration Number
- NCT04283539
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸The Melanoma and Skin Cancer Institute, Denver, Colorado, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
Suspended
- Conditions
- Aspirin-Sensitive AsthmaAspirin Exacerbated Respiratory DiseaseNasal Polyps
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 245
- Registration Number
- NCT04261582
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Asthma and Intimate Partner Violence
- Conditions
- Domestic ViolenceAsthma
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2020-01-06
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 60
- Registration Number
- NCT04216680
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Skin Characteristics of Parents of Food Allergic Pediatric Patients
Suspended
- Conditions
- Food Allergy in Children
- Interventions
- Diagnostic Test: Skin tape strippingDevice: Skin barrier assessmentDiagnostic Test: Blood draw
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 160
- Registration Number
- NCT04198753
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Skin Tape Transcriptome Methods in Children
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Other: Skin tape strips
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 20
- Registration Number
- NCT04180644
- Locations
- 🇺🇸
National Jewish Health and University of Colorado Denver, Denver, Colorado, United States
Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 50
- Registration Number
- NCT04093232
- Locations
- 🇺🇸
national Jewish health, Denver, Colorado, United States
Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum
- Conditions
- Health Controls Without AtopyAtopic Dermatitis With a History of Eczema HerpeticumAtopic Dermatitis Without a History of Eczema Herpeticum
- Interventions
- Biological: Xolair
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 36
- Registration Number
- NCT04060550
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Use of Blinded Tapering for Hypnotic Discontinuation
Phase 3
Active, not recruiting
- Conditions
- Hypnotic Dependence Among Those with Insomnia
- Interventions
- Behavioral: Hypnotic Medication Blinded TaperBehavioral: Hypnotic Medication Open-Label Taper
- First Posted Date
- 2019-08-08
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 260
- Registration Number
- NCT04050176
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath